ASTE1 Inhibitors
ASTE1 inhibitors comprise a diverse array of chemical compounds that orchestrate a diminution in the functional activity of ASTE1 through intricate cellular mechanisms. For instance, the organoselenium compound Ebselen and the histone deacetylase inhibitor Trichostatin A engage in cellular processes that mitigate oxidative stress and modify gene expression, respectively. These actions potentially lead to the indirect suppression of ASTE1, assuming it is involved in ROS-related signaling or is subject to regulation by chromatin remodeling. Likewise, the specific inhibition of key kinases and signaling nodes by compounds such as Rapamycin, SB 203580, LY 294002, PD 98059, and U0126 disrupts crucial pathways, such as mTOR, p38 MAPK, PI3K/AKT, and MAPK/ERK, which could be essential for ASTE1's activity in the context of cell cycle progression, stress response, or cellular growth. Additionally, Chelerythrine and Celastrol target PKC and heat shock proteins, respectively, which may destabilize cellular conditions that favor ASTE1 activity, particularly if ASTE1 is a client protein of the chaperones or is regulated by PKC-mediated signaling.
Continuing with the theme of targeted pathway disruption, SP600125, 3-Methyladenine (3-MA), and Cyclopamine serve as inhibitors of JNK, autophagy, and Hedgehog signaling pathways, respectively. SP600125's inhibition of the JNK signaling, involved in cellular stress responses, and 3-Methyladenine's blockade of autophagic processes, are especially relevant if ASTE1 is linked to the regulation of apoptosis or autophagy. Lastly, Cyclopamine's antagonistic effect on the Hedgehog pathway could curtail ASTE1 activity if it is implicated in the downstream signaling of this pathway. Collectively, these inhibitors demonstrate a multi-faceted approach to attenuating the functional activity of ASTE1 by intervening in various biochemical routes that, while not directly inhibiting ASTE1, create an environment that is less conducive to its activity.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ebselen | 60940-34-3 | sc-200740B sc-200740 sc-200740A | 1 mg 25 mg 100 mg | $33.00 $136.00 $458.00 | 5 | |
Ebselen is an organoselenium compound that mimics glutathione peroxidase, leading to a decrease in reactive oxygen species (ROS). As ROS can be involved in the activation of certain signaling cascades that could upregulate ASTE1 activity, the reduction of ROS by Ebselen may indirectly diminish ASTE1 activity. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor which alters chromatin structure and gene expression. By affecting gene expression patterns, it could downregulate the cellular pathways that are necessary for the optimal functioning of ASTE1, thereby diminishing its activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor that can halt the progression of the cell cycle. Given that ASTE1 function may be tied to cell cycle dynamics, inhibition of mTOR signaling could indirectly result in decreased ASTE1 function. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB 203580 is a p38 MAPK inhibitor. By inhibiting p38 MAPK, which is part of the MAPK signaling pathway involved in stress and inflammatory responses, it could indirectly result in the downregulation of ASTE1, if ASTE1 is implicated in these cellular responses. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY 294002 is a PI3K inhibitor that prevents the phosphorylation of PIP2 to PIP3, which is necessary for AKT activation. As AKT signaling can regulate various proteins and cellular processes, inhibiting PI3K could impede pathways that enhance ASTE1 activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD 98059 is a MEK inhibitor, which blocks the MAPK/ERK pathway. This pathway is implicated in cell growth and differentiation, and inhibiting it can indirectly reduce ASTE1 function if ASTE1 is part of these cellular processes. | ||||||
Chelerythrine chloride | 3895-92-9 | sc-3547 sc-3547A | 5 mg 25 mg | $90.00 $317.00 | 17 | |
Chelerythrine is a potent inhibitor of protein kinase C (PKC). As PKC is involved in numerous signaling cascades, its inhibition could disrupt pathways that otherwise would contribute to maintaining or increasing ASTE1 activity. | ||||||
Celastrol, Celastrus scandens | 34157-83-0 | sc-202534 | 10 mg | $158.00 | 6 | |
Celastrol is a quinone methide triterpenoid that has been shown to inhibit heat shock proteins (Hsp). Heat shock proteins can stabilize many client proteins, so their inhibition by Celastrol may reduce the stabilization and activity of ASTE1 if it is a client protein. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of JNK, part of the MAP kinase pathway. JNK signaling is involved in apoptosis and cell differentiation; hence, its inhibition could hinder pathways that potentially increase ASTE1 activity. | ||||||
Autophagy Inhibitor, 3-MA | 5142-23-4 | sc-205596 sc-205596A | 50 mg 500 mg | $65.00 $261.00 | 113 | |
3-Methyladenine (3-MA) is an autophagy inhibitor known to block the PI3K class III, which is involved in the early stages of autophagy. If ASTE1 activity is related to autophagy, inhibiting this pathway could indirectly reduce its function. | ||||||